InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the full record of transactions filed by Glass Russell Monroe. Officer active across 1 company, notably Evolent Health, Inc.. Aggregated, 5 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €46k. Activity tracked since 1 March 2024. The latest transaction was disclosed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Glass Russell Monroe is a Director at Evolent Health, Inc. The 5 total filings, all of which are included in the 5 most recent sampled filings, concern Evolent Health, Inc., with EUR 46372 of buys and EUR 0 of sells over the sampled period from 2024-03-05 to 2026-06-08. The modal transaction nature is Attribution.